Menu

• Ask a Health Expert about CENTRAL NERVOUS SYSTEM LEUKAEMIA
• Post Your Side Effect related to CENTRAL NERVOUS SYSTEM LEUKAEMIA
• CENTRAL NERVOUS SYSTEM LEUKAEMIA and FDA Warnings
• CENTRAL NERVOUS SYSTEM LEUKAEMIA in Patients Wiki
• Report CENTRAL NERVOUS SYSTEM LEUKAEMIA in Drug Side Effect Survey

CENTRAL NERVOUS SYSTEM LEUKAEMIA side effect

What is CENTRAL NERVOUS SYSTEM LEUKAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Imatinib Side Effects Report #5449613-9
Health Professional from AUSTRIA reported IMATINIB MESYLATE problem on Sept 04, 2007. Male patient, 52 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: central nervous system leukaemia, coordination abnormal, fistula, headache, paraesthesia, paresis, surgery, . IMATINIB MESYLATE dosage: 600 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5311348-0
GLEEVEC problem was reported by a Consumer or non-health professional from JAPAN on Apr 18, 2007. Male patient, 76 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: central nervous system leukaemia, osteomyelitis fungal, . GLEEVEC dosage: 400 MG/D. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient recovered.

Trisenox Side Effects Report #5643136-X
Physician from JAPAN reported TRISENOX problem on Feb 13, 2008. Male patient, 53 years of age, was diagnosed with acute promyelocytic leukaemia, convulsion prophylaxis and was treated with TRISENOX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, catheter site infection, central nervous system leukaemia, electrocardiogram qt prolonged, hepatic function abnormal, herpes zoster, meningitis, pancytopenia, pseudomonas infection, . TRISENOX dosage: 10.425 MG QD INTRAVENOUS DRIP. During the same period patient was treated with VALPROATE, CYTARABINE, METHOTREXATE, PREDNISOLONE ACETATE, NAFAMOSTATE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5472254-4
REVLIMID problem was reported by a Physician from UNITED STATES on Sept 21, 2007. Male patient, 73 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: aortic calcification, calcinosis, central nervous system leukaemia, meningism, platelet count decreased, pulmonary granuloma, sepsis, somnolence, white blood cell count increased, . REVLIMID dosage: 50 MG, DAILY X14 DAYS, ORAL. During the same period patient was treated with HYDROXYUREA, ALLOPURINOL, CIPROFLOXACIN, VALTREX. Patient was hospitalized. Patient died on 07/02/2007.